Literature DB >> 29167694

Computational modeling to improve treatments for essential tremor.

Shane Lee1, Wael F Asaad1,2,3,4, Stephanie R Jones1,5.   

Abstract

Essential tremor (ET) is a neurological disorder of unknown etiology that is typically characterized by an involuntary periodic movement of the upper limbs. No longer considered monosymptomatic, ET patients often have additional motor and even cognitive impairments. Although there are several pharmacological treatments, no drugs have been developed specifically for ET [1], and 30-70% of patients are medication-refractory [2]. A subset of medication-refractory patients may benefit from electrical deep brain stimulation (DBS) of the ventral intermediate nucleus of the thalamus (VIM), which receives cerebellar inputs. Abnormal cerebellar input to VIM is presumed to be a major contributor to tremor symptoms, which is alleviated by DBS. Computational modeling of the effects of DBS in VIM has been a powerful tool to design DBS protocols to reduce tremor activity. However, far less is known about how these therapies affect non-tremor symptoms, and more experimental and computational modeling work is required to address these growing considerations. Models capable of addressing multiple facets of ET will lead to novel, more efficient treatment.

Entities:  

Year:  2016        PMID: 29167694      PMCID: PMC5695882          DOI: 10.1016/j.ddmod.2017.04.002

Source DB:  PubMed          Journal:  Drug Discov Today Dis Models        ISSN: 1740-6757


  82 in total

1.  Deep brain stimulation creates an informational lesion of the stimulated nucleus.

Authors:  Warren M Grill; Andrea N Snyder; Svjetlana Miocinovic
Journal:  Neuroreport       Date:  2004-05-19       Impact factor: 1.837

2.  Spatial steering of deep brain stimulation volumes using a novel lead design.

Authors:  H C F Martens; E Toader; M M J Decré; D J Anderson; R Vetter; D R Kipke; Kenneth B Baker; Matthew D Johnson; Jerrold L Vitek
Journal:  Clin Neurophysiol       Date:  2010-08-21       Impact factor: 3.708

Review 3.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

4.  Modeling parkinsonian circuitry and the DBS electrode. II. Evaluation of a computer simulation model of the basal ganglia with and without subthalamic nucleus stimulation.

Authors:  J L Shils; L Z Mei; J E Arle
Journal:  Stereotact Funct Neurosurg       Date:  2007-12-14       Impact factor: 1.875

5.  Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease.

Authors:  A L Benabid; P Pollak; A Louveau; S Henry; J de Rougemont
Journal:  Appl Neurophysiol       Date:  1987

6.  Personality in essential tremor: further evidence of non-motor manifestations of the disease.

Authors:  A Chatterjee; E C Jurewicz; L M Applegate; E D Louis
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

Review 7.  Essential tremor--neurodegenerative or nondegenerative disease towards a working definition of ET.

Authors:  Günther Deuschl; Rodger Elble
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 8.  Engineering the next generation of clinical deep brain stimulation technology.

Authors:  Cameron C McIntyre; Ashutosh Chaturvedi; Reuben R Shamir; Scott F Lempka
Journal:  Brain Stimul       Date:  2014-07-30       Impact factor: 8.955

9.  Essential tremor course and disability: A clinicopathologic study of 20 cases.

Authors:  Alexander Rajput; Christopher A Robinson; Ali H Rajput
Journal:  Neurology       Date:  2004-03-23       Impact factor: 9.910

Review 10.  Closing the loop of deep brain stimulation.

Authors:  Romain Carron; Antoine Chaillet; Anton Filipchuk; William Pasillas-Lépine; Constance Hammond
Journal:  Front Syst Neurosci       Date:  2013-12-20
View more
  1 in total

Review 1.  Technology of deep brain stimulation: current status and future directions.

Authors:  Joachim K Krauss; Nir Lipsman; Tipu Aziz; Alexandre Boutet; Peter Brown; Jin Woo Chang; Benjamin Davidson; Warren M Grill; Marwan I Hariz; Andreas Horn; Michael Schulder; Antonios Mammis; Peter A Tass; Jens Volkmann; Andres M Lozano
Journal:  Nat Rev Neurol       Date:  2020-11-26       Impact factor: 42.937

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.